In 2022, Sinovac Biotech Ltd., one of China’s major vaccine producers, recorded an annual revenue of 1492.76 billion U.S. dollars. In comparison to 2020, the company's annual revenue increased almost 37 times in 2021, reaching almost 20 billion U.S. dollars.
CoronaVac
Sinovac's substantial growth is largely driven by the strong demand for CoronaVac, its COVID-19 vaccine. By the end of January 2022, almost 2.5 billion doses of CoronaVac were manufactured in production sites within China and abroad, ranking Sinovac as one of the most prominent COVID-19 vaccine suppliers globally.
The international market
Unlike CanSino Biologics Inc., which heavily relies on international sales, Sinovac sold most of its products within China’s borders. However, a considerable share of Sinovac’s COVID-19 vaccine doses was also exported through sales and donations, primarily to middle-income economies. The inactivated vaccine is adopted by dozens of countries and recognized by the World Health Organization, despite having a lower efficacy rate against COVID-19 than mRNA vaccines such as Comirnaty and Moderna’s Spikevax.
Annual revenue of Sinovac Biotech Ltd. between 2016 and 2022
(in million U.S. dollars)
Characteristic
Revenue in million U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
US Securities and Exchange Commission. (May 1, 2023). Annual revenue of Sinovac Biotech Ltd. between 2016 and 2022 (in million U.S. dollars) [Graph]. In Statista. Retrieved August 24, 2024, from https://www.statista.com/statistics/1304534/annual-revenue-of-sinovac/
US Securities and Exchange Commission. "Annual revenue of Sinovac Biotech Ltd. between 2016 and 2022 (in million U.S. dollars)." Chart. May 1, 2023. Statista. Accessed August 24, 2024. https://www.statista.com/statistics/1304534/annual-revenue-of-sinovac/
US Securities and Exchange Commission. (2023). Annual revenue of Sinovac Biotech Ltd. between 2016 and 2022 (in million U.S. dollars). Statista. Statista Inc.. Accessed: August 24, 2024. https://www.statista.com/statistics/1304534/annual-revenue-of-sinovac/
US Securities and Exchange Commission. "Annual Revenue of Sinovac Biotech Ltd. between 2016 and 2022 (in Million U.S. Dollars)." Statista, Statista Inc., 1 May 2023, https://www.statista.com/statistics/1304534/annual-revenue-of-sinovac/
US Securities and Exchange Commission, Annual revenue of Sinovac Biotech Ltd. between 2016 and 2022 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1304534/annual-revenue-of-sinovac/ (last visited August 24, 2024)
Annual revenue of Sinovac Biotech Ltd. between 2016 and 2022 (in million U.S. dollars) [Graph], US Securities and Exchange Commission, May 1, 2023. [Online]. Available: https://www.statista.com/statistics/1304534/annual-revenue-of-sinovac/